Are they monitoring to improve their product or to use the information to produce more copycat drugs that may not have the forums' ratings as too many side effects? I have no trust in pharmaceutical companies. For those companies reading this, if the survey read :

How would you rate our pharmaceutical industry in terms of effectively producing innovative products, on a scale of 0 being no trust and 5 being very trustworthy, My responce would be a big fat 0.

How could we improve? Simple, first no lobbying of congressional persons either Federal or State, Stop Advertising drugs on TV, ( do you really think the public is stupid enough to believe the actress who while talking to her friends listing all potential side effects of a drug didn't memorize the lines you wrote for her?) Generally after hearing the side effects, your product is a turnoff.

No more cover ups by releasing research information about new products on a "What the Public Needs to Know" while leaving out the some serious side effect to rush your product to the market.

Stop using patients for research only to look for information or responces from the participants proving your brand name drug is better than someone elses that does the same thing. This type of research does not help the patient to derive information about the disease under study, but is strictly for marketing purpose. Don't hand them your typical research contract stating the patient should not expect to receive anything, the research is to be used for the interest of science. Try the truth for a change. Tell the patient it is for marketing purposes and offer him a cut of the increase in revenue the study makes.

Finally, under no circumstances should you even contemplate getting patents on gene information found from patients volunteering blood. The blood they donated is nature and cannot be patented. The intention of the patient participating in gene research is to benefit all mankind, not to give your company the right to buy the rights to the information and patent it. Patents of gene lines will only slow the research process and empower the larger drug companies to squash the growth of smaller independent research by not allowing them to research a gene line which may cause a secondary effect on another disease.

Got It You Lurkers?
Vicky